Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)

Market Cap	10.67B
Revenue (ttm)	6.91B
Net Income (ttm)	893.09M
Shares Out	178.70M
EPS (ttm)	5.00
PE Ratio	11.95
Forward PE	n/a
Dividend	2.80 (4.66%)
Ex-Dividend Date	Aug 6, 2025

Volume	240,816
Average Volume	240,557
Open	60.10
Previous Close	60.10
Day's Range	59.20 - 60.10
52-Week Range	51.20 - 64.90
Beta	-0.03
RSI	49.94
Earnings Date	Feb 25, 2026

About TPE:1720

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicine, cosmetics, beverage, normal instruments, and medical instruments. It also sells various medical supplements, as well as preventive medicine; and imports and exports various medical products, medicine, supplements, nourishment, and function food. In addition, the company is involved in wholesale of multi-function printers and information softwa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1720

Financial Performance

In 2024, TPE:1720's revenue was 6.79 billion, an increase of 8.81% compared to the previous year's 6.24 billion. Earnings were 880.50 million, an increase of 5.46%.